Structural definition of a conserved neutralization epitope on HIV-1 gp120

被引:626
作者
Zhou, Tongqing
Xu, Ling
Dey, Barna
Hessell, Ann J.
Van Ryk, Donald
Xiang, Shi-Hua
Yang, Xinzhen
Zhang, Mei-Yun
Zwick, Michael B.
Arthos, James
Burton, Dennis R.
Dimitrov, Dimiter S.
Sodroski, Joseph
Wyatt, Richard
Nabel, Gary J.
Kwong, Peter D.
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA
[3] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[4] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[5] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[6] Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA
[7] NCI, Ctr Canc Res, Frederick, MD 21702 USA
关键词
D O I
10.1038/nature05580
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The remarkable diversity, glycosylation and conformational flexibility of the human immunodeficiency virus type 1 (HIV-1) envelope (Env), including substantial rearrangement of the gp120 glycoprotein upon binding the CD4 receptor, allow it to evade antibody-mediated neutralization. Despite this complexity, the HIV-1 Env must retain conserved determinants that mediate CD4 binding. To evaluate how these determinants might provide opportunities for antibody recognition, we created variants of gp120 stabilized in the CD4-bound state, assessed binding of CD4 and of receptor-binding-site antibodies, and determined the structure at 2.3 angstrom resolution of the broadly neutralizing antibody b12 in complex with gp120. b12 binds to a conformationally invariant surface that overlaps a distinct subset of the CD4-binding site. This surface is involved in the metastable attachment of CD4, before the gp120 rearrangement required for stable engagement. A site of vulnerability, related to a functional requirement for efficient association with CD4, can therefore be targeted by antibody to neutralize HIV-1.
引用
收藏
页码:732 / 737
页数:6
相关论文
共 50 条
  • [1] Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein - Implications for therapeutic and vaccine strategies
    Arthos, J
    Cicala, C
    Steenbeke, TD
    Chun, TW
    Cruz, CD
    Hanback, DB
    Khazanie, P
    Nam, D
    Schuck, P
    Selig, SM
    Van Ryk, D
    Chaikin, MA
    Fauci, AS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) : 11456 - 11464
  • [2] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [3] A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates
    Barouch, DH
    Yang, ZY
    Kong, WP
    Korioth-Schmitz, B
    Sumida, SM
    Truitt, DM
    Kishko, MG
    Arthur, JC
    Miura, A
    Mascola, JR
    Letvin, NL
    Nabel, GJ
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (14) : 8828 - 8834
  • [4] Crystallography & NMR system:: A new software suite for macromolecular structure determination
    Brunger, AT
    Adams, PD
    Clore, GM
    DeLano, WL
    Gros, P
    Grosse-Kunstleve, RW
    Jiang, JS
    Kuszewski, J
    Nilges, M
    Pannu, NS
    Read, RJ
    Rice, LM
    Simonson, T
    Warren, GL
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 : 905 - 921
  • [5] EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY
    BURTON, DR
    PYATI, J
    KODURI, R
    SHARP, SJ
    THORNTON, GB
    PARREN, PWHI
    SAWYER, LSW
    HENDRY, RM
    DUNLOP, N
    NARA, PL
    LAMACCHIA, M
    GARRATTY, E
    STIEHM, ER
    BRYSON, YJ
    CAO, YZ
    MOORE, JP
    HO, DD
    BARBAS, CF
    [J]. SCIENCE, 1994, 266 (5187) : 1024 - 1027
  • [6] Antibodies, viruses and vaccines
    Burton, DR
    [J]. NATURE REVIEWS IMMUNOLOGY, 2002, 2 (09) : 706 - 713
  • [7] BURTON DR, 1997, AIDS SA, V11, P587
  • [8] Effects of N-butyldeoxynojirimycin and the Lec3.2.8.1 mutant phenotype on N-glycan processing in Chinese hamster ovary cells:: Application to glycoprotein crystallization
    Butters, TD
    Sparks, LM
    Harlos, K
    Ikemizu, S
    Stuart, DI
    Jones, EY
    Davis, SJ
    [J]. PROTEIN SCIENCE, 1999, 8 (08) : 1696 - 1701
  • [9] Core structure of gp41 from the HIV envelope glycoprotein
    Chan, DC
    Fass, D
    Berger, JM
    Kim, PS
    [J]. CELL, 1997, 89 (02) : 263 - 273
  • [10] Structure of an unliganded simian immunodeficiency virus gp120 core
    Chen, B
    Vogan, EM
    Gong, HY
    Skehel, JJ
    Wiley, DC
    Harrison, SC
    [J]. NATURE, 2005, 433 (7028) : 834 - 841